Journals / Solunum / 2012 / Cilt: 14 - Sayı: 2

Tuberculosis in the elderly

Yaşlı hastalarda tüberküloz

Journal
Solunum
Pages
59–62
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

To minimize the risk of hepatotoxicity, careful pretreatment assessment is needed to balance the benefit against this potential risk.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Tuberculosis (TB) is an infectious disease that can affect people of any age, gender, or socioeconomic class.
📊
Key Findings & Data:It is more prevalent in some sections of the population and this situation is taken under consideration in implementing TB control programs.
💡
Conclusion & Impact:To minimize the risk of hepatotoxicity, careful pretreatment assessment is needed to balance the benefit against this potential risk.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Tuberculosis (TB) is an infectious disease that can affect people of any age, gender, or socioeconomic class. It is more prevalent in some sections of the population and this situation is taken under consideration in implementing TB control programs. While TB affects mostly the productive age groups in high prevalence countries, it remains an important challenge in the elderly in low prevalence countries. The atypical clinical and radiological presentation of TB in the elderly and comorbidities can lead to delayed diagnosis and appropriate treatment. Considering TB in differential diagnosis is the cornerstone of a rapid diagnosis. Management of active TB in the elderly does not differ fundamentally from that in younger patients. Standart treatment is used. The incidence of adverse effects is higher in the elderly compared to the younger patients. Successful treatment outcomes are lower and TB-related mortality is higher in the elderly patients. The diagnosis and treatment of latent TB infection should be considered in risk groups. To minimize the risk of hepatotoxicity, careful pretreatment assessment is needed to balance the benefit against this potential risk.

Özet

Tüberküloz (TB) her yaştan, cinsiyetten ve sosyoekonomik sınıftan insanı etkileyen bir infeksiyon hastalığıdır. Ancak toplumun belli kesimlerinde daha sık görülmekte ve bu durum TB kontrol programlarının yapılandırılmasında göz önüne alınmaktadır. Prevalansın yüksek olduğu ülkelerde üretken yaş gruplarını etkilerken, prevalansın düşük olduğu ülkelerde yaşlılarda önemli bir sorundur. Yaşlılarda klinik ve radyolojik bulguların atipik olması ve komorbiditeler nedeniyle tanıda ve uygun tedaviye başlamada gecikmeler olabilmektedir. Hızlı tanının temeli ayırıcı tanıda TB’nin düşünülmesidir. Yaşlılarda aktif TB’nin tedavisi temelde gençlerden farklı değildir. Standart tedavi kullanılır. Ancak yan etkiler gençlerden daha fazla görülmektedir. Yaşlı hastalarda tedavi başarısı daha düşük, TB’ye bağlı mortalite daha yüksektir. Risk grubundaki yaşlılarda latent TB infeksiyonu tanı ve tedavisi yapılmalıdır. Ancak hepatotoksisite riskini azaltmak için tedavi öncesi değerlendirmeler yapılmalı, yarar/zarar oranı doğru dengelenmelidir.

🔖

Cite This Article

KÖKSAL, D. (2012). Tuberculosis in the elderly. Solunum, Cilt: 14 - Sayı: 2, 59–62. https://ajindex.com/articles/314333

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Mori T, Leung CL. Tuberculosis in the global aging population. Infect Dis Clin N Am 2010;24:751-768
  2. Meyers JA. Tuberculosis in the aged. Postgrad Med 1967;41:214-222
  3. Crossley K, Peterson PK. Infections in the elderly-New developments. In: Remington JS, Swartz MN, eds. In: Current Clinical Topics in Infectious Diseases. Malden, Mass, Blackwell Science; 1998:75-100
  4. Türkiye’de Verem Savaşı 2010 Raporu. Hamza Bozkurt (editör), T.C. Verem Savaş Daire Başkanlığı, Ankara 2010
  5. Alvarez S, Shell C, Berk SL. Pulmonary tuberculosis in elderly man. Am J Med 1987;82:602-606
  6. Korzeniewska-Kosela M, Krysl J, Müller N, Black W, Allen E, FitzGerald JM. Tuberculosis in young adults and the elderly. A prospective comparison study. Chest 1994;106:28-32
  7. Chan CH, Woo J, Or KK, Chan RC, Cheung W. The effect of age on the presentation of patients with tuberculosis. Tuber Lung Dis 1995;76:290-294
  8. Ataç G, Sevim T, Özmen İ, Kapaklı N, Aksoy E, Öngen A ve ark. Yaşlı hastalarda tüberkülozun klinik ve laboratuvar özellikleri. Tüberküloz ve Toraks Dergisi 2002;50:258-263
  9. Leung CC, Yew WW, Chan CK, Chau CH, Tam CM, Lam CW, et al. Tuberculosis in older people: a retrospective and comparative study from Hong Kong. J Am Geriatr Soc 2002;50:1219-1226
  10. Umeki S. Comparison of younger and elderly patients with pulmonary tuberculosis. Respiration 1989;55:75-83
  11. Perez-Guzman C, Torres-Cruz A, Villarreal-Velarde H, Vargas MH. Progressive age related changes in pulmonary tuberculosis images and the effect of diabetes. Am J Respir Crit Care Med 2000;162:1738-1740
  12. Schaberg T, Rebhan K, Lode H. Risk factors fors ide effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur Respir J 1996;9:2026-2030
  13. Tatar D, Keskin Ö, Özacar R, Halilçolar H. Genç ve yaşlı hastalarda tüberkülozun benzer ve farklı yönleri. Tüberküloz ve Toraks Dergisi 2002;50:485-491
  14. Kolsuz M, Küçükkebapçı C, Ersoy M. Genç ve yaşlı grupta yeni tüberküloz olgularının karşılaştırılması. Toraks Dergisi 2005;6:62-67
  15. Das SK. A study of pulmonary tuberculosis in the elderly. J Indian Med Assoc 2007;105:432, 436, 438-9. Yaşlı Hastalarda Tüberküloz Solunum Dergisi t Deniz Köksal 61 16. Lee JH, Han DH, Song JW, Chung HS. Diagnostic and therapeutic problems of pulmonary tuberculosis in elderly patients. J Korean Med Sci 2005;20:784-789
  16. Van den Brande P, Vijgen J, Demedts M. Clinical spectrum of pulmonary tuberculosis in older patients: